• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用生酮饮食和氯胺酮治疗慢性神经性厌食症缓解:病例报告

Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report.

作者信息

Scolnick Barbara, Zupec-Kania Beth, Calabrese Lori, Aoki Chiye, Hildebrandt Thomas

机构信息

Internal Medicine & Addiction Medicine, Waban, MA, United States.

Consultant-Ketogenic Diet Therapy LLC, Elm Grove, WI, United States.

出版信息

Front Psychiatry. 2020 Jul 30;11:763. doi: 10.3389/fpsyt.2020.00763. eCollection 2020.

DOI:10.3389/fpsyt.2020.00763
PMID:32848935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7412264/
Abstract

BACKGROUND

Chronic anorexia nervosa is a tragic disease with no known effective pharmacological or behavioral treatment. We report the case of a 29 year-old woman who struggled with severe and enduring anorexia nervosa for 15 years, and experienced a complete recovery following a novel treatment of adopting a ketogenic diet followed by ketamine infusions. Her remission has persisted for over 6 months.

CASE PRESENTATION

At age 14.5, the patient embarked on an effort to "eat healthy." She quickly lost control of the dieting, developed associated compulsions and obsessions about food, body dissatisfaction, emotional lability, and lost nearly 13.6 kilograms (30 pounds). She was hospitalized for 6 weeks, and while she regained some weight, she did not attain full weight restoration. For 15 years, she continued to eat in a restrictive manner, exercise compulsively, and have intermittent periods of alcohol dependence. Nevertheless, she always hoped to get well, and at age 29, she began a novel treatment for anorexia nervosa.

CONCLUSIONS

This is the first report of a ketogenic diet used specifically for the treatment of anorexia nervosa, followed by a short series of titrated IV ketamine infusions leading to complete remission of severe and enduring anorexia nervosa, with weight restoration, and sustained cessation of cognitive and behavioral symptoms, for 6 months. Although these treatments were used sequentially the relationship between these modalities, and possible synergy, is unclear, and deserves further study. Complete and sustained remission of chronic anorexia nervosa is quite rare, and the novel use of a ketogenic diet and IV ketamine treatment in this potentially lethal condition suggests avenues for further research, and hope for patients and their families.

摘要

背景

慢性神经性厌食症是一种悲惨的疾病,目前尚无已知有效的药物或行为治疗方法。我们报告了一名29岁女性的病例,她与严重且持久的神经性厌食症抗争了15年,在采用生酮饮食随后进行氯胺酮输注的新治疗方法后实现了完全康复。她的缓解状态已持续超过6个月。

病例介绍

14.5岁时,患者开始努力“健康饮食”。她很快就无法控制饮食,出现了与食物相关的强迫观念和强迫行为、身体不满、情绪不稳定,并减重近13.6公斤(30磅)。她住院6周,虽然体重有所恢复,但并未完全恢复到正常体重。在接下来的15年里,她继续以限制饮食的方式进食,强迫性锻炼,并间歇性地出现酒精依赖。尽管如此,她一直希望康复,29岁时,她开始了一种针对神经性厌食症的新治疗方法。

结论

这是首例专门使用生酮饮食治疗神经性厌食症的报告,随后进行了短疗程的滴定静脉注射氯胺酮,导致严重且持久的神经性厌食症完全缓解,体重恢复,认知和行为症状持续消失达6个月。尽管这些治疗是相继使用的,但这些治疗方式之间的关系以及可能存在的协同作用尚不清楚,值得进一步研究。慢性神经性厌食症的完全且持续缓解非常罕见,在这种潜在致命疾病中对生酮饮食和静脉注射氯胺酮治疗的新应用为进一步研究指明了方向,并给患者及其家人带来了希望。

相似文献

1
Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report.采用生酮饮食和氯胺酮治疗慢性神经性厌食症缓解:病例报告
Front Psychiatry. 2020 Jul 30;11:763. doi: 10.3389/fpsyt.2020.00763. eCollection 2020.
2
Synergy between ketamine and ketogenic diet in anorexia nervosa, and other neurobehavioral disorders.氯胺酮与生酮饮食在神经性厌食症及其他神经行为障碍中的协同作用。
Eat Weight Disord. 2023 Feb 14;28(1):8. doi: 10.1007/s40519-023-01528-5.
3
Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study.生酮饮食联合氯胺酮输注治疗对神经性厌食症慢性持续性进食障碍心理病理的影响:一项初步研究。
Eat Weight Disord. 2022 Dec;27(8):3751-3757. doi: 10.1007/s40519-022-01455-x. Epub 2022 Aug 23.
4
Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.使用心理治疗辅助静脉注射氯胺酮改善重度及持续性神经性厌食症合并重度抑郁症患者的抑郁症状:一例报告
J Eat Disord. 2024 Jun 12;12(1):79. doi: 10.1186/s40337-024-01039-3.
5
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.病例报告:极端且持久的神经性贪食症经反复氯胺酮辅助心理治疗后意外缓解
Front Psychiatry. 2021 Nov 17;12:764112. doi: 10.3389/fpsyt.2021.764112. eCollection 2021.
6
Apnea with ketamine sedation in a patient with severe anorexia nervosa: A case report.厌食症患者氯胺酮镇静后发生呼吸暂停:病例报告。
Eat Weight Disord. 2022 Feb;27(1):387-389. doi: 10.1007/s40519-021-01176-7. Epub 2021 Mar 31.
7
Case report: cognitive performance in an extreme case of anorexia nervosa with a body mass index of 7.7.病例报告:一例体重指数为 7.7 的极重度神经性厌食症患者的认知表现。
BMC Psychiatry. 2020 Jun 5;20(1):284. doi: 10.1186/s12888-020-02701-1.
8
[3-year course after successful therapy of extreme anorexia nervosa].[极端神经性厌食症成功治疗后的三年疗程]
Nervenarzt. 2018 Sep;89(9):1063-1068. doi: 10.1007/s00115-018-0592-3.
9
A case report of anorexia nervosa in a 23-year-old Ethiopian woman.一名23岁埃塞俄比亚女性神经性厌食症的病例报告。
Clin Case Rep. 2023 Nov 20;11(11):e8150. doi: 10.1002/ccr3.8150. eCollection 2023 Nov.
10
A clinical course of a patient with anorexia nervosa receiving surgery for superior mesenteric artery syndrome.一名神经性厌食症患者接受肠系膜上动脉综合征手术的临床病程。
J Eat Disord. 2021 Jun 30;9(1):79. doi: 10.1186/s40337-021-00436-2.

引用本文的文献

1
Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders.治疗与物质使用障碍共病的饮食失调的新型潜在药理学方法。
Biomed Pharmacother. 2025 Aug;189:118327. doi: 10.1016/j.biopha.2025.118327. Epub 2025 Jul 4.
2
Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa.通过解离重新建立联系:一项关于氯胺酮辅助心理治疗神经性厌食症的5个月随访案例研究。
J Eat Disord. 2025 Jun 10;13(1):107. doi: 10.1186/s40337-025-01313-y.
3
Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis.氯胺酮作为饮食失调的辅助治疗:一项病例系列探索性研究及回顾性分析。
J Eat Disord. 2025 Mar 17;13(1):48. doi: 10.1186/s40337-025-01232-y.
4
[Pharmacotherapy of eating disorders-An update].[饮食失调的药物治疗——最新进展]
Nervenarzt. 2025 May;96(3):230-237. doi: 10.1007/s00115-025-01804-y. Epub 2025 Feb 20.
5
Pharmacotherapeutic strategies for the treatment of anorexia nervosa - novel targets to break a vicious cycle.治疗神经性厌食症的药物治疗策略——打破恶性循环的新靶点。
Expert Opin Pharmacother. 2024 Dec;25(17):2253-2265. doi: 10.1080/14656566.2024.2424316. Epub 2024 Nov 5.
6
Therapeutic ketogenic diet as treatment for anorexia nervosa.治疗性生酮饮食作为神经性厌食症的治疗方法。
Front Nutr. 2024 Sep 4;11:1392135. doi: 10.3389/fnut.2024.1392135. eCollection 2024.
7
Ultra-Processed Foods and Mental Health: Where Do Eating Disorders Fit into the Puzzle?超加工食品与心理健康:饮食失调在这个谜题中处于什么位置?
Nutrients. 2024 Jun 19;16(12):1955. doi: 10.3390/nu16121955.
8
Complete remission of depression and anxiety using a ketogenic diet: case series.采用生酮饮食实现抑郁和焦虑的完全缓解:病例系列
Front Nutr. 2024 May 14;11:1396685. doi: 10.3389/fnut.2024.1396685. eCollection 2024.
9
Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.使用心理治疗辅助静脉注射氯胺酮改善重度及持续性神经性厌食症合并重度抑郁症患者的抑郁症状:一例报告
J Eat Disord. 2024 Jun 12;12(1):79. doi: 10.1186/s40337-024-01039-3.
10
Established and emerging treatments for eating disorders.已确立和新兴的进食障碍治疗方法。
Trends Mol Med. 2024 Apr;30(4):392-402. doi: 10.1016/j.molmed.2024.02.009. Epub 2024 Mar 18.

本文引用的文献

1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells.生酮饮食改变肠道微生物组,导致肠道 Th17 细胞减少。
Cell. 2020 Jun 11;181(6):1263-1275.e16. doi: 10.1016/j.cell.2020.04.027. Epub 2020 May 20.
2
Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men.生酮疗法在神经退行性和精神疾病中的应用:从老鼠到人类。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109913. doi: 10.1016/j.pnpbp.2020.109913. Epub 2020 Mar 6.
3
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression.评估单一剂量氯胺酮治疗抵抗性抑郁症相关副作用的综合评估。
J Affect Disord. 2020 Feb 15;263:568-575. doi: 10.1016/j.jad.2019.11.028. Epub 2019 Nov 10.
4
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa.全基因组关联研究确定了 8 个风险位点,并提示神经性厌食症与代谢-精神起源有关。
Nat Genet. 2019 Aug;51(8):1207-1214. doi: 10.1038/s41588-019-0439-2. Epub 2019 Jul 15.
5
Hypothesis: Clues From Mammalian Hibernation for Treating Patients With Anorexia Nervosa.假设:来自哺乳动物冬眠的线索用于治疗神经性厌食症患者。
Front Psychol. 2018 Nov 12;9:2159. doi: 10.3389/fpsyg.2018.02159. eCollection 2018.
6
Single injection of ketamine during mid-adolescence promotes long-lasting resilience to activity-based anorexia of female mice by increasing food intake and attenuating hyperactivity as well as anxiety-like behavior.青春期中期单次注射氯胺酮可通过增加食物摄入和减弱过度活跃及类似焦虑样行为,促进雌性小鼠对抗活动限制型厌食症的持久恢复能力。
Int J Eat Disord. 2018 Aug;51(8):1020-1025. doi: 10.1002/eat.22937. Epub 2018 Aug 13.
7
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.氯胺酮及其代谢产物的药理学:治疗机制的新视角。
Pharmacol Rev. 2018 Jul;70(3):621-660. doi: 10.1124/pr.117.015198.
8
Treatment outcome reporting in anorexia nervosa: time for a paradigm shift?神经性厌食症的治疗结果报告:是时候进行范式转变了吗?
J Eat Disord. 2018 May 7;6:10. doi: 10.1186/s40337-018-0195-1. eCollection 2018.
9
Anorexia Nervosa and Comorbid Psychopathology.神经性厌食症与共病精神病理学
Endocr Metab Immune Disord Drug Targets. 2018;18(4):316-324. doi: 10.2174/1871530318666180213111637.
10
Long-term outcome of anorexia nervosa: Results from a large clinical longitudinal study.神经性厌食症的长期预后:一项大型临床纵向研究的结果
Int J Eat Disord. 2017 Sep;50(9):1018-1030. doi: 10.1002/eat.22736. Epub 2017 Jun 23.